| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |